Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128


The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism.

Moors CC, Blaak EE, van der Zijl NJ, Diamant M, Goossens GH.

J Clin Endocrinol Metab. 2013 May;98(5):E891-6. doi: 10.1210/jc.2012-4067. Epub 2013 Apr 3.


Skeletal muscle fatty acid handling in insulin resistant men.

van Hees AM, Jans A, Hul GB, Roche HM, Saris WH, Blaak EE.

Obesity (Silver Spring). 2011 Jul;19(7):1350-9. doi: 10.1038/oby.2011.10. Epub 2011 Feb 17.


Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose.

Goossens GH, Moors CC, Jocken JW, van der Zijl NJ, Jans A, Konings E, Diamant M, Blaak EE.

Nutrients. 2016 Mar 14;8(3):164. doi: 10.3390/nu8030164.


PUFAs acutely affect triacylglycerol-derived skeletal muscle fatty acid uptake and increase postprandial insulin sensitivity.

Jans A, Konings E, Goossens GH, Bouwman FG, Moors CC, Boekschoten MV, Afman LA, Müller M, Mariman EC, Blaak EE.

Am J Clin Nutr. 2012 Apr;95(4):825-36. doi: 10.3945/ajcn.111.028787. Epub 2012 Feb 15.


Effects of dietary fat modification on skeletal muscle fatty acid handling in the metabolic syndrome.

van Hees AM, Saris WH, Hul GB, Schaper NC, Timmerman BE, Lovegrove JA, Roche HM, Blaak EE.

Int J Obes (Lond). 2010 May;34(5):859-70. doi: 10.1038/ijo.2010.6. Epub 2010 Feb 2.


Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial.

Goossens GH, Moors CC, van der Zijl NJ, Venteclef N, Alili R, Jocken JW, Essers Y, Cleutjens JP, Clément K, Diamant M, Blaak EE.

PLoS One. 2012;7(6):e39930. doi: 10.1371/journal.pone.0039930. Epub 2012 Jun 29.


Altered skeletal muscle fatty acid handling is associated with the degree of insulin resistance in overweight and obese humans.

van der Kolk BW, Goossens GH, Jocken JW, Blaak EE.

Diabetologia. 2016 Dec;59(12):2686-2696. Epub 2016 Sep 15.


Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.

Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE.

Obesity (Silver Spring). 2008 May;16(5):1025-32. doi: 10.1038/oby.2008.24. Epub 2008 Feb 28.


Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.

Moors CC, van der Zijl NJ, Diamant M, Blaak EE, Goossens GH.

Int J Obes (Lond). 2012 May;36(5):709-17. doi: 10.1038/ijo.2011.123. Epub 2011 Jun 28.


The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F.

Diabetologia. 2005 Jan;48(1):83-95. Epub 2004 Dec 24.


Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia.

Evans K, Burdge GC, Wootton SA, Collins JM, Clark ML, Tan GD, Karpe F, Frayn KN.

Atherosclerosis. 2008 Mar;197(1):164-70. Epub 2007 Apr 26.


Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage.

Ruge T, Hodson L, Cheeseman J, Dennis AL, Fielding BA, Humphreys SM, Frayn KN, Karpe F.

J Clin Endocrinol Metab. 2009 May;94(5):1781-8. doi: 10.1210/jc.2008-2090. Epub 2009 Feb 17.


Reduced oxidation of dietary fat after a short term high-carbohydrate diet.

Roberts R, Bickerton AS, Fielding BA, Blaak EE, Wagenmakers AJ, Chong MF, Gilbert M, Karpe F, Frayn KN.

Am J Clin Nutr. 2008 Apr;87(4):824-31.


Carbohydrate supplementation during prolonged cycling exercise spares muscle glycogen but does not affect intramyocellular lipid use.

Stellingwerff T, Boon H, Gijsen AP, Stegen JH, Kuipers H, van Loon LJ.

Pflugers Arch. 2007 Jul;454(4):635-47. Epub 2007 Feb 27.


Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.

Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ.

J Appl Physiol (1985). 2006 May;100(5):1467-74. Epub 2005 Dec 15.


Impact of dietary fat quantity and quality on skeletal muscle fatty acid metabolism in subjects with the metabolic syndrome.

Jans A, van Hees AM, Gjelstad IM, Sparks LM, Tierney AC, Risérus U, Drevon CA, Schrauwen P, Roche HM, Blaak EE.

Metabolism. 2012 Nov;61(11):1554-65. doi: 10.1016/j.metabol.2012.04.003. Epub 2012 Jun 1.


Characterisation of fatty acid metabolism in different insulin-resistant phenotypes by means of stable isotopes.

Blaak EE.

Proc Nutr Soc. 2017 Jan 19:1-7. doi: 10.1017/S0029665116003013. [Epub ahead of print]


Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.

Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA, Saris WH.

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E146-54.


Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.

Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ.

J Clin Endocrinol Metab. 2001 Apr;86(4):1638-44.


Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial.

van der Zijl NJ, Moors CC, Goossens GH, Hermans MM, Blaak EE, Diamant M.

Diabetes Care. 2011 Apr;34(4):845-51. doi: 10.2337/dc10-2224. Epub 2011 Feb 17.

Supplemental Content

Support Center